WCG and InformedDNA have established a new center for genetics and precision medicine in clinical trials – the increasing complexity of which, while potentially daunting, also creates the opportunity for transformational value, say industry experts.
Pfizer halts production at Hospira site after Form 483
from in-PharmaTechnologist.com
T cell cytokine ‘backpacks’ target solid tumours
from BioPharma-Reporter.com
US FDA launches drug shortages task force
from in-PharmaTechnologist.com
AstraZeneca and 4D Molecular Therapeutics explore gene therapy for lung disease
from BioPharma-Reporter.com
Warning, recall, alert: Unsanitary lab conditions raise US FDA alarm
Patient safety
The nexus of innovation, policy improvements changing at never-before-seen pace: DIA
Transparency on trial
GSK taps TrialScope for clinical trial transparency
Transparency on trial
Challenge Accepted: Clinipace rebrands flexible, personalized CRO model
Clinical evolution
